Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04430738
Title Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.

colorectal cancer

gastric adenocarcinoma

gallbladder carcinoma


esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma


Fluorouracil + Leucovorin + Oxaliplatin + Trastuzumab + Tucatinib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.